Pellet Production Lines
The pelletizing process for the production of pharmaceutical pellets - including extrusion and spheronization, production of pellets by powder layering and liquid layering and pelletization via melt and wet granulation processes.
Producing Pharmaceutical Pellets
Pharmaceutical pellets offer a number of additional features compared with conventional tablets. GEA is a market-leading supplier of pelletization equipment and process solutions, and can help you to select the system that best suits your needs.
The GEA Advantage
Specialising in the design, build and supply of equipment for the production and laboratory development of pharmaceutical pellets (spheroids) by extrusion and spheronization, powder and liquid layering, high shear pellet processing, and
Products
Showing 4 of 10
AirConnect Fluid Bed Processor & Coater
Committed to providing flexible, modular equipment to support research and development in the pharmaceutical industry, the multipurpose AirConnect from GEA delivers a range of fluid bed processing solutions for small-scale applications.
FlexStream Fluid Bed Processor
FlexStream is a multi-purpose processor that addresses the shortfalls of traditional fluid bed processing, including linear scale-up, fully contained loading and unloading for Pharmaceutical applications.
Fluid Bed R&D Processing of Pharmaceuticals
A complete range of technologies for R&D designed for specific applications, our small-scale range covers every aspect of pharma oral solid dosage production, from high shear mixers, fluid bed dryers and single pot systems to extruders and spheronizers, blenders and containment solutions, right through to tablet compression.
Liquid Layering of Pellets by Fluid Bed Processing
Built-in versatility - For maximum process flexibility, GEA can supply a single Fluid Bed unit or FlexStream fluid bed processing – granulation, drying & pellet coating in one unit.
Downloads
GEA Insights
Turning wastewater into value
GEA centrifuges enable wastewater reuse, resource recovery, and water security by turning biosolids into value in a world facing growing water scarcity.
Around the world in seven questions: New foods we’ll love
Last year was not a year of hyped-up headlines for alternative proteins. Perhaps that is precisely why it was an important year for food biotech, the biotechnology behind everyday foods and ingredients. While the sector worked through a difficult funding environment, approvals were still granted, pilot lines set up and new platforms tested in the background. In short: headlines are turning into infrastructure. Frederieke Reiners heads GEA’s New Food business. She and her team work at the intersection of biotechnology and industrial food production. In this interview, she takes us on a world tour of food biotech in seven questions.
How freeze-dried pet food raises the bar
Pets are family – and owners expect premium, transparent and sustainable nutrition. Freeze-drying, powered by GEA technology, helps pet food makers deliver.
